Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk"

Myocardial contrast echocardiography has been shown recently to accurately assess the "area at risk" for necrosis after acute coronary occlusion in the experimental model. Risk area quantitation, however, has been studied primarily from single tomographic planes. Because the three-dimensional extent of myocardial necrosis depends on the total volume of myocardium at risk, the total left ventricular "area at risk" was determined in 11 dogs (Group A) with either left anterior descending or left circumflex artery occlusion using contrast echocardiography and compared with risk area determined by technetium autoradiography. An excellent correlation was found between the two methods (r = 0.96%, y = 0.91x + 1.5, p less than 0.001, SEE = 3.17). A comparison of risk area for individual levels of the left ventricle using both methods, however, showed some variation in the degree of correlation, with the poorest fit being apparent at the apex. To identify the source of the variation, errors caused by data registration were minimized in six additional dogs (Group B) by implanting epicardial markers at a single level and measuring "area at risk" at this level using both methods. When no registration error was present, the correlation between the two methods was excellent (r = 0.99, y = 0.92x + 2.6, p less than 0.001, SEE = 0.55). In conclusion, the "area at risk" for infarction after acute coronary occlusion can be determined accurately for the entire left ventricle as well as for a single tomographic slice using myocardial contrast echocardiography. This was validated using technetium autoradiography, which is an established method of determining "area at risk" in the experimental setting.

This article has been cited by other articles:

				T. Lockie, E. Nagel, S. Redwood, and S. Plein Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes Circulation, March 31, 2009; 119(12): 1671 - 1681. [Full Text] [PDF]

				S. Kaul Myocardial Contrast Echocardiography: A 25-Year Retrospective Circulation, July 15, 2008; 118(3): 291 - 308. [Full Text] [PDF]

				B. L. Gerber Risk area, infarct size, and the exposure of the wavefront phenomenon of myocardial necrosis in humans Eur. Heart J., July 2, 2007; 28(14): 1670 - 1672. [Full Text] [PDF]

				H. Leong-Poi, M. P. Coggins, J. Sklenar, A. R. Jayaweera, X.-Q. Wang, and S. Kaul Role of collateral blood flow in the apparent disparity between the extent of abnormal wall thickening and perfusion defect size during acute myocardial infarction and demand ischemia J. Am. Coll. Cardiol., February 15, 2005; 45(4): 565 - 572. [Abstract] [Full Text] [PDF]

				S. B. Feinstein The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H450 - H457. [Abstract] [Full Text] [PDF]

				H. Kunichika, B. Peters, B. Cotter, H. Masugata, N. Kunichika, P. L. Wolf, and A. N. DeMaria Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: Quantitative analysis J. Am. Coll. Cardiol., August 6, 2003; 42(3): 552 - 557. [Abstract] [Full Text] [PDF]

				A.S Petronio, D Rovai, G Musumeci, R Baglini, C Nardi, U Limbruno, C Palagi, D Volterrani, and M Mariani Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty Eur. Heart J., January 1, 2003; 24(1): 67 - 76. [Abstract] [Full Text] [PDF]

				O Kamp, W Lepper, J.-L Vanoverschelde, B.C Aeschbacher, D Rovai, P Assayag, P Voci, Y Kloster, A Distante, and C.A Visser Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography Eur. Heart J., August 2, 2001; 22(16): 1485 - 1495. [Abstract] [PDF]

				C. Teupe, M. Takeuchi, J. Yao, E. Avelar, and N. Pandian Detection of Viable Myocardium by Transvenous Myocardial Contrast Echocardiography Using Harmonic Power Doppler : Canine Model of Acute Coronary Occlusion and Reperfusion Chest, August 1, 2001; 120(2): 567 - 572. [Abstract] [Full Text] [PDF]

				F. F. Immer, A. M. Seiler, B. C. Aeschbacher, F. Mahler, H. Saner, and H. Saner Influence of the Ultrasound Contrast Agent Levovist(R) on Human Nailfold Capillary Microcirculation Angiology, February 1, 2000; 51(2): 123 - 129. [Abstract] [PDF]

				S. Kaul Myocardial Contrast Echocardiography : 15 Years of Research and Development Circulation, November 18, 1997; 96(10): 3745 - 3760. [Full Text]

				F. S. Villanueva, G. Camarano, S. Ismail, N. C. Goodman, J. Sklenar, and S. Kaul Coronary Reserve Abnormalities in the Infarcted Myocardium: Assessment of Myocardial Viability Immediately Versus Late After Reflow by Contrast Echocardiography Circulation, August 15, 1996; 94(4): 748 - 754. [Abstract] [Full Text]